{"id":557225,"date":"2021-08-11T16:52:02","date_gmt":"2021-08-11T16:52:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=557225"},"modified":"2021-08-11T16:52:02","modified_gmt":"2021-08-11T16:52:02","slug":"psoriasis-market-analysis-market-size-epidemiology-leading-companies-and-competitive-analysis-by-delveinsight","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/psoriasis-market-analysis-market-size-epidemiology-leading-companies-and-competitive-analysis-by-delveinsight_557225.html","title":{"rendered":"Psoriasis Market Analysis, Market Size, Epidemiology, Leading Companies And Competitive Analysis By DelveInsight"},"content":{"rendered":"
\n
\"Psoriasis<\/a><\/div>\n
\n
DelveInsight Business Research LLP<\/div>\n<\/div>\n<\/div>\n
DelveInsight’s “Psoriasis – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Psoriasis, historical and forecasted epidemiology as well as the Psoriasis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n<\/div>\n

DelveInsight has launched a new report on “Psoriasis – Market Insights, Epidemiology, and Market Forecast-2030”.<\/a><\/strong><\/p>\n

DelveInsight’s“Psoriasis – Market Insights, Epidemiology, and Market Forecast-2030″<\/a>report deliver an in-depth understanding of the Psoriasis, historical and forecasted epidemiology as well as the Psoriasis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/strong><\/p>\n

\"\"<\/strong><\/p>\n

Some of the key facts of the Report:<\/strong><\/p>\n

    \n
  1. \n

    According to a research study, up to 40 % of patients with psoriasis go on to develop PsA, usually within 5-10 years of cutaneous disease onset.<\/p>\n<\/li>\n

  2. \n

    The study reported the incidence of psoriasis in all ages, with the incidence of the disease varying from 31.4 per 100 000 person-years in eastern Europe (Russia) to 521.1 per 100 000 person-years in western Europe (Germany).<\/p>\n<\/li>\n

  3. \n

    According to a study, psoriasis Vulgaris represents 90% of cases, psoriasis arthropathic around 4%, followed by guttate type psoriasis (3%), psoriatic erythroderma (1%), and generalized pustular psoriasis (1%) in Japan.<\/p>\n<\/li>\n<\/ol>\n

    Key benefits of the report:<\/strong><\/p>\n

      \n
    1. \n

      Psoriasis market report covers a descriptive overview and comprehensive insight of the Psoriasis Epidemiology and Psoriasis  market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)<\/p>\n<\/li>\n

    2. \n

      The Psoriasis market report provides insights on the current and emerging therapies.<\/p>\n<\/li>\n

    3. \n

      Psoriasis market report provides a global historical and forecasted market covering drug outreach in 7MM.<\/p>\n<\/li>\n

    4. \n

      The Psoriasis market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Psoriasis market.<\/p>\n<\/li>\n<\/ol>\n

      Got queries? Click here to know more about Psoriasis Market Landscape.<\/a><\/strong><\/p>\n

      Psoriasis Overview<\/strong><\/p>\n

      Psoriasis is a chronic, immune-mediated inflammatory skin disease characterized by the presence of papules and plaques occurring most commonly on the elbows, knees, scalp, and lower back, but is not limited to these areas. <\/p>\n

      The key players involved in the Psoriasis market:<\/strong><\/p>\n